196 related articles for article (PubMed ID: 2047567)
1. Hepatotoxicity of eugenol in mice depleted of glutathione by treatment with DL-buthionine sulfoximine.
Mizutani T; Satoh K; Nomura H; Nakanishi K
Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):219-30. PubMed ID: 2047567
[TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity of butylated hydroxytoluene and its analogs in mice depleted of hepatic glutathione.
Mizutani T; Nomura H; Nakanishi K; Fujita S
Toxicol Appl Pharmacol; 1987 Jan; 87(1):166-76. PubMed ID: 3798451
[TBL] [Abstract][Full Text] [Related]
3. Styrene-induced hepatotoxicity in mice depleted of glutathione.
Mizutani T; Irie Y; Nakanishi K
Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):361-74. PubMed ID: 7712112
[TBL] [Abstract][Full Text] [Related]
4. Hepatotoxicity of eugenol and related compounds in mice depleted of glutathione: structural requirements for toxic potency.
Mizutani T; Satoh K; Nomura H
Res Commun Chem Pathol Pharmacol; 1991 Jul; 73(1):87-95. PubMed ID: 1882130
[TBL] [Abstract][Full Text] [Related]
5. p-Dichlorobenzene-induced hepatotoxicity in mice depleted of glutathione by treatment with buthionine sulfoximine.
Mizutani T; Nakahori Y; Yamamoto K
Toxicology; 1994; 94(1-3):57-67. PubMed ID: 7801330
[TBL] [Abstract][Full Text] [Related]
6. Metabolism-dependent hepatotoxicity of methimazole in mice depleted of glutathione.
Mizutani T; Murakami M; Shirai M; Tanaka M; Nakanishi K
J Appl Toxicol; 1999; 19(3):193-8. PubMed ID: 10362270
[TBL] [Abstract][Full Text] [Related]
7. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
Ravindranath V; Boyd MR
Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
[TBL] [Abstract][Full Text] [Related]
8. Nephrotoxicity of thiazoles structurally related to thiabendazole in mice depleted of glutathione by treatment with buthionine sulfoximine.
Mizutani T; Yoshida K; Ito K
Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):29-38. PubMed ID: 1626124
[TBL] [Abstract][Full Text] [Related]
9. Metabolism-dependent hepatotoxicity of amodiaquine in glutathione-depleted mice.
Shimizu S; Atsumi R; Itokawa K; Iwasaki M; Aoki T; Ono C; Izumi T; Sudo K; Okazaki O
Arch Toxicol; 2009 Jul; 83(7):701-7. PubMed ID: 19479240
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
Ishikawa M; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the acute toxicity of methyl chloride in male B6C3F1 mice by glutathione depletion.
Chellman GJ; White RD; Norton RM; Bus JS
Toxicol Appl Pharmacol; 1986 Oct; 86(1):93-104. PubMed ID: 3764938
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine.
Mizutani T; Ito K; Nomura H; Nakanishi K
Food Chem Toxicol; 1990 Mar; 28(3):169-77. PubMed ID: 2344991
[TBL] [Abstract][Full Text] [Related]
13. A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine.
Watanabe T; Sagisaka H; Arakawa S; Shibaya Y; Watanabe M; Igarashi I; Tanaka K; Totsuka S; Takasaki W; Manabe S
J Toxicol Sci; 2003 Dec; 28(5):455-69. PubMed ID: 14746349
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
Standeven AM; Wetterhahn KE
Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
[TBL] [Abstract][Full Text] [Related]
15. Effects of buthionine sulfoximine and cysteine on the hepatotoxicity of butylated hydroxytoluene in rats.
Nakagawa Y
Toxicol Lett; 1987 Aug; 37(3):251-6. PubMed ID: 3617099
[TBL] [Abstract][Full Text] [Related]
16. Effect of buthionine sulfoximine on orthophenylphenol-induced hepato- and nephrotoxic potential in male rats.
Nakagawa Y; Tayama K
Arch Toxicol; 1988; 62(6):452-7. PubMed ID: 3250375
[TBL] [Abstract][Full Text] [Related]
17. Pneumotoxicity and hepatotoxicity of styrene and styrene oxide.
Gadberry MG; DeNicola DB; Carlson GP
J Toxicol Environ Health; 1996 Jun; 48(3):273-94. PubMed ID: 8656450
[TBL] [Abstract][Full Text] [Related]
18. Hepatotoxicity after 3'-hydroxyacetanilide administration to buthionine sulfoximine pretreated mice.
Tirmenstein MA; Nelson SD
Chem Res Toxicol; 1991; 4(2):214-7. PubMed ID: 1782350
[TBL] [Abstract][Full Text] [Related]
19. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
[TBL] [Abstract][Full Text] [Related]
20. Induction of rat UDP-glucuronosyltransferase and glutathione S-transferase activities by L-buthionine-S,R-sulfoximine without induction of cytochrome P-450.
Manning BW; Franklin MR
Toxicology; 1990 Dec; 65(1-2):149-59. PubMed ID: 2125759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
